Ascofuranone

Ascofuranone
Structural formula of ascofuranone
Space-filling model of the ascofuranone molecule
Names
Preferred IUPAC name
3-Chloro-5-{(2E,6E)-7-[(2S)-5,5-dimethyl-4-oxooxolan-2-yl]-3-methylocta-2,6-dien-1-yl}-4,6-dihydroxy-2-methylbenzaldehyde
Other names
Ascofuranon
Identifiers
3D model (JSmol)
ChEBI
ChEMBL
ChemSpider
UNII
  • InChI=1S/C23H29ClO5/c1-13(7-6-8-14(2)18-11-19(26)23(4,5)29-18)9-10-16-21(27)17(12-25)15(3)20(24)22(16)28/h8-9,12,18,27-28H,6-7,10-11H2,1-5H3/b13-9+,14-8+/t18-/m0/s1 checkY
    Key: VGYPZLGWVQQOST-JUERRSSISA-N checkY
  • InChI=1/C23H29ClO5/c1-13(7-6-8-14(2)18-11-19(26)23(4,5)29-18)9-10-16-21(27)17(12-25)15(3)20(24)22(16)28/h8-9,12,18,27-28H,6-7,10-11H2,1-5H3/b13-9+,14-8+/t18-/m0/s1
    Key: VGYPZLGWVQQOST-JUERRSSIBJ
  • O=Cc1c(O)c(c(O)c(Cl)c1C)C/C=C(/CC/C=C(\C)[C@H]2OC(C(=O)C2)(C)C)C
Properties
C23H29ClO5
Molar mass 420.93 g·mol−1
Density 1.207 g/mL
Boiling point 581.2 °C (1,078.2 °F; 854.4 K)
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
☒N verify (what is checkY☒N ?)

Ascofuranone is an antibiotic produced by various ascomycete fungi including Acremonium sclerotigenum[1] that inhibits the Trypanosoma brucei alternative oxidase and is a lead compound in efforts to produce other drugs targeting this enzyme for the treatment of sleeping sickness.[2] The compound is effective both in vitro cell culture and in infections in mice.[3]

Ascofuranone has also been reported to have anti-tumor activity,[4] and modulate the immune system.[5]

  1. ^ Hijikawa Y, Matsuzaki M, Suzuki S, Inaoka DK, Tatsumi R, Kido Y, Kita K (March 2017). "Re-identification of the ascofuranone-producing fungus Ascochyta viciae as Acremonium sclerotigenum". The Journal of Antibiotics. 70 (3): 304–307. doi:10.1038/ja.2016.132. PMID 27804952. S2CID 11725030.
  2. ^ Minagawa N, Yabu Y, Kita K, Nagai K, Ohta N, Meguro K, et al. (February 1997). "An antibiotic, ascofuranone, specifically inhibits respiration and in vitro growth of long slender bloodstream forms of Trypanosoma brucei brucei". Molecular and Biochemical Parasitology. 84 (2): 271–280. doi:10.1016/S0166-6851(96)02797-1. PMID 9084049.
  3. ^ Yabu Y, Yoshida A, Suzuki T, Nihei C, Kawai K, Minagawa N, et al. (June 2003). "The efficacy of ascofuranone in a consecutive treatment on Trypanosoma brucei brucei in mice". Parasitology International. 52 (2): 155–164. doi:10.1016/S1383-5769(03)00012-6. PMID 12798927.
  4. ^ Magae J, Hayasaki J, Matsuda Y, Hotta M, Hosokawa T, Suzuki S, et al. (July 1988). "Antitumor and antimetastatic activity of an antibiotic, ascofuranone, and activation of phagocytes". The Journal of Antibiotics. 41 (7): 959–965. doi:10.7164/antibiotics.41.959. PMID 3417568.
  5. ^ Magae J, Suzuki S, Nagai K, Yamasaki M, Ando K, Tamura G (March 1986). "In vitro effects of an antitumor antibiotic, ascofuranone, on the murine immune system". Cancer Research. 46 (3): 1073–1078. PMID 3080231.